Peter DeMuth

Peter DeMuth

Company: Elicio Therapeutics

Job title: Chief Scientific Officer


Unveiling the Potential of RAS-Targeted Vaccines as a Durable & Versatile Immunotherapy Solution 11:45 am

• How to elicit robust immune responses against KRAS with vaccination formats? • How to enhance the action of key immune cells and generate robust tumor-specific immune responses? • What challenges need to be overcome to expand development of vaccines for more complex cancers?Read more

day: Day One Track A AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.